[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know",
    "summary": "Boston Scientific (BSX) concluded the recent trading session at $98.50, signifying a -1.55% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=425080fee5cccfa46b85b82c84a7c3fadb81646db3f4969e90457cfbdc5c6830",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743717613,
      "headline": "Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know",
      "id": 133704810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) concluded the recent trading session at $98.50, signifying a -1.55% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=425080fee5cccfa46b85b82c84a7c3fadb81646db3f4969e90457cfbdc5c6830"
    }
  },
  {
    "ts": null,
    "headline": "Global Expansion in EPD and Innovations Support Abbott Stock",
    "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
    "url": "https://finnhub.io/api/news?id=8e63b4a42f3d60a3636c838d53e13188568b52a038de0ed83fa2735c3003ba05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743701100,
      "headline": "Global Expansion in EPD and Innovations Support Abbott Stock",
      "id": 133699153,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.",
      "url": "https://finnhub.io/api/news?id=8e63b4a42f3d60a3636c838d53e13188568b52a038de0ed83fa2735c3003ba05"
    }
  },
  {
    "ts": null,
    "headline": "AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands",
    "summary": "ANGO reports solid fiscal third-quarter earnings with continued strength in its Med Tech segment. The expansion of gross margin bodes well.",
    "url": "https://finnhub.io/api/news?id=f828404702dcbad57ee1717b5c4e041ddb0db9e91a2408e8ba05a89c346a8a77",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743700380,
      "headline": "AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands",
      "id": 133699154,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ANGO reports solid fiscal third-quarter earnings with continued strength in its Med Tech segment. The expansion of gross margin bodes well.",
      "url": "https://finnhub.io/api/news?id=f828404702dcbad57ee1717b5c4e041ddb0db9e91a2408e8ba05a89c346a8a77"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=1bfc3476f288441b8e490bd7b8294f7d56c9c7e63310abce6b57e6f4eac2fed1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743698100,
      "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
      "id": 133707731,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=1bfc3476f288441b8e490bd7b8294f7d56c9c7e63310abce6b57e6f4eac2fed1"
    }
  },
  {
    "ts": null,
    "headline": "Medical Device Stocks Fall on Tariff Hit",
    "summary": "President Trump’s tariffs will hit pacemakers, X-ray machines and other medical devices manufactured overseas and shipped to the U.S.  Devices and diagnostic equipment are made all over the world, from China and Europe to Malaysia and Vietnam.  Many manufacturers are well positioned to weather tariffs because patients will need to get their products, but Wells Fargo estimated companies’ annual earnings per share could take a hit as much as 13.8% in the case of Bausch & Lomb.",
    "url": "https://finnhub.io/api/news?id=79a435b3a215b0a74d1807cecbb6258d499a8eb487d54512ca5b42e7777eaca1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743691114,
      "headline": "Medical Device Stocks Fall on Tariff Hit",
      "id": 133697771,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "President Trump’s tariffs will hit pacemakers, X-ray machines and other medical devices manufactured overseas and shipped to the U.S.  Devices and diagnostic equipment are made all over the world, from China and Europe to Malaysia and Vietnam.  Many manufacturers are well positioned to weather tariffs because patients will need to get their products, but Wells Fargo estimated companies’ annual earnings per share could take a hit as much as 13.8% in the case of Bausch & Lomb.",
      "url": "https://finnhub.io/api/news?id=79a435b3a215b0a74d1807cecbb6258d499a8eb487d54512ca5b42e7777eaca1"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Boston Scientific (BSX) is a Strong Growth Stock",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=b7de52931ec87928f6df93fb7b8249eb6db559fcd35e582578f77a483622505b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743687906,
      "headline": "Here's Why Boston Scientific (BSX) is a Strong Growth Stock",
      "id": 133697772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=b7de52931ec87928f6df93fb7b8249eb6db559fcd35e582578f77a483622505b"
    }
  },
  {
    "ts": null,
    "headline": "Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?",
    "summary": "BRKR announces first successful customer installation of novel d-DNP Polarizer at UCSF.",
    "url": "https://finnhub.io/api/news?id=d1a28056d62cf997ee24eb2d15b666260cca8bf3aa27d9fe1cd56fd6fbdc068a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743686460,
      "headline": "Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain?",
      "id": 133697773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BRKR announces first successful customer installation of novel d-DNP Polarizer at UCSF.",
      "url": "https://finnhub.io/api/news?id=d1a28056d62cf997ee24eb2d15b666260cca8bf3aa27d9fe1cd56fd6fbdc068a"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Hold Bio-Rad Stock in Your Portfolio?",
    "summary": "BIO continues to attract investors' attention due to its robust performance in the ddPCR platform.",
    "url": "https://finnhub.io/api/news?id=c1c3cba012dd2c989b321d7425fa8722a76034dd70349f5bfad9554f8ef36d9e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743685200,
      "headline": "Should You Continue to Hold Bio-Rad Stock in Your Portfolio?",
      "id": 133697774,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BIO continues to attract investors' attention due to its robust performance in the ddPCR platform.",
      "url": "https://finnhub.io/api/news?id=c1c3cba012dd2c989b321d7425fa8722a76034dd70349f5bfad9554f8ef36d9e"
    }
  },
  {
    "ts": null,
    "headline": "ALC Stock May Rise With the Introduction of PanOptix Pro in US",
    "summary": "Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.",
    "url": "https://finnhub.io/api/news?id=399771a642f6df04f5e3c4546308aed279f11e158cc29abb47809ada44abc51e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743681360,
      "headline": "ALC Stock May Rise With the Introduction of PanOptix Pro in US",
      "id": 133697775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.",
      "url": "https://finnhub.io/api/news?id=399771a642f6df04f5e3c4546308aed279f11e158cc29abb47809ada44abc51e"
    }
  },
  {
    "ts": null,
    "headline": "AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK",
    "summary": "Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.",
    "url": "https://finnhub.io/api/news?id=94d405d9cb2468c9aa462d43d36176549ea0ae8c535c782d4fa67ab335be19b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743681240,
      "headline": "AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK",
      "id": 133697776,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.",
      "url": "https://finnhub.io/api/news?id=94d405d9cb2468c9aa462d43d36176549ea0ae8c535c782d4fa67ab335be19b1"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific (NYSE:BSX) A Risky Investment?",
    "summary": "Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...",
    "url": "https://finnhub.io/api/news?id=2c7f45b48c52ceccbb98799f1cb8eb9dc0f9cb5905bdf232da0bf2152d9e5f52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743678014,
      "headline": "Is Boston Scientific (NYSE:BSX) A Risky Investment?",
      "id": 133697777,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...",
      "url": "https://finnhub.io/api/news?id=2c7f45b48c52ceccbb98799f1cb8eb9dc0f9cb5905bdf232da0bf2152d9e5f52"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific’s Farapulse matches Medtronic cryoablation in trial",
    "summary": "Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.",
    "url": "https://finnhub.io/api/news?id=76748eb75dca6eabe30893ad302d0fae3380470ed41b8615c740793bea0d21cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743673020,
      "headline": "Boston Scientific’s Farapulse matches Medtronic cryoablation in trial",
      "id": 133697778,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.",
      "url": "https://finnhub.io/api/news?id=76748eb75dca6eabe30893ad302d0fae3380470ed41b8615c740793bea0d21cf"
    }
  }
]